Medtronic announced that its Intellis™ neurostimulator and the Vanta™ neurostimulator have both received approval from the U.S. Food and Drug Administration (FDA) for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN), in a January 24, 2022 press release. The approval grants patients suffering from DPN access to both products within Medtronic’s spinal cord stimulation (SCS) portfolio. The IntellisTM neurostimulator is rechargeable whereas the VantaTM neurostimulator is recharge-free .
DPN, also referred to also as painful diabetic neuropathy (PDN), is a neurological disorder that impacts about 30% of individuals with diabetes, according to the press release. DPN occurs when high blood sugar levels damage nerves causing numbness, burning, or stabbing pain. Charlie Covert, a Medtronic vice president and general manager, views the new approvals as another example of Medtronic’s expertise:
DPN is a significant challenge for patients with diabetes, leading to disability and a diminished quality of life . . . This new indication enables us to apply Medtronic’s more than 40 years of proven SCS experience, as well as the company’s deep diabetes expertise, to deliver better care to even greater numbers of diabetes patients
According to the press release, Medtronic estimates that the US market revenue for SCS treatment of chronic pain associated with DPN is approximately $70 million and expects market revenue to grow to $300 million by fiscal year 2026.
With the new approval, Medtronic’s IntellisTM and VantaTM neurostimulator products now join Nevro’sHFXTM for PDN as the only SCS devices with FDA approval for treatment of DPN/PDN. Nevro’s Chairman, CEO, and President, D. Keith Grossman, responded to the FDA’s approval of the IntellisTM and VantaTM neurostimulators in a press release, stating:
PDN represents a very large potential market, and having another competitor validate this large opportunity speaks to its attractiveness.
Nevro announced the FDA’s approval of its HFXTM on July 19, 2021.
MONTREAL, Jan. 26, 2022 /CNW Telbec/ – Air Canada’s flight AC2201 today from Vancouver to Beijing marks the first of three special charter flights transporting Team Canada to the Beijing 2022 Olympic and Paralympic Winter Games. The airline also named its…
Founded in 2000, Corporate Aircraft Charter is a largely diversified air charter company, with operations that span across the business aviation sector. Its operations include private, FIFO, and aeromedical flight services, with contracts that cater to government agencies, tourism providers and the oil and gas sectors. To learn more about the company, Australian Aviation sat
Former RAAF pilot Alexander Robinson is the co-founder of Airly, a start-up that allows customers to book business jet flights via an app. Here, he predicts what this year has in store for the industry after it welcomed a new generation of customers in 2020 COVID-19’s savaging of the aviation industry will continue to be
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Gatos Silver, Inc. (“Gatos Silver” or the “Company”) (NYSE: GATO) investors concerning the Company’s possible violations of the federal securities laws. If you suffered a loss on your Gatos […]
REX IS an airline renowned for doing things differently. As Australia’s largest regional airline, our rich history is peppered with examples of innovative approaches and ‘out-of-the-box’ thinking. This explains how a small regional airline can make more accumulated absolute profits than Qantas since the global financial crisis of 2008 and arrive at the pandemic with
Marijuana headlines from around the world in 60 seconds or less! Get 6 cannabis news stories from different countries and read them all in 60 seconds or less. What is new in the marijuana industry today as the world prepares for full legalization.
Opioids and cannabis are primarily used as analgesics. Both function remarkably well for relieving chronic pain. Since the start of medical cannabis programs in states across the U.S. and Canada, statistics show that patients prefer the use of cannabis to opioids. This caused a 40% reduction in the use of opioids
Manual cryptocurrency trading is a difficult and perilous endeavor. Not only is there a steep learning curve to consider, but traders frequently make missteps that could have been prevented. Furthermore, the decision-making part of trading is critical, and automation tools are gaining traction in this area. Manual Crypto Trading’s Drawbacks People who are interested in […]